{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:33:34Z","timestamp":1792719214834,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,10,12]],"date-time":"2015-10-12T00:00:00Z","timestamp":1444608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1038\/nm.3961","type":"journal-article","created":{"date-parts":[[2015,10,12]],"date-time":"2015-10-12T13:29:23Z","timestamp":1444656563000},"page":"1262-1271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":366,"title":["Excess TGF-\u03b2 mediates muscle weakness associated with bone metastases in mice"],"prefix":"10.1038","volume":"21","author":[{"given":"David L","family":"Waning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid S","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Reiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0493-062X","authenticated-orcid":false,"given":"Wenjun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutha","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Chiechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa","family":"Umanskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Niewolna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trupti","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahba","family":"Charkhzarrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Khatiwada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anetta","family":"Wronska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Serena","family":"Benassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A","family":"Witzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gehua","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G David","family":"Roodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa A","family":"Guise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,12]]},"reference":[{"key":"BFnm3961_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","volume":"16","author":"KC Fearon","year":"2012","unstructured":"Fearon, K.C., Glass, D.J. & Guttridge, D.C. Cancer cachexia: mediators, signaling and metabolic pathways. Cell Metab. 16, 153\u2013166 (2012).","journal-title":"Cell Metab."},{"key":"BFnm3961_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/mus.21796","volume":"43","author":"BA Gentry","year":"2011","unstructured":"Gentry, B.A., Ferreira, J.A., Phillips, C.L. & Brown, M. Hindlimb skeletal muscle function in myostatin-deficient mice. Muscle Nerve 43, 49\u201357 (2011).","journal-title":"Muscle Nerve"},{"key":"BFnm3961_CR3","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1152\/japplphysiol.00126.2006","volume":"101","author":"CL Mendias","year":"2006","unstructured":"Mendias, C.L., Marcin, J.E., Calerdon, D.R. & Faulkner, J.A. Contractile properties of EDL and soleus muscles of myostatin-deficient mice. J. Appl. Physiol. 101, 898\u2013905 (2006).","journal-title":"J. Appl. Physiol."},{"key":"BFnm3961_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrc3055","volume":"11","author":"KN Weilbaecher","year":"2011","unstructured":"Weilbaecher, K.N., Guise, T.A. & McCauley, L.K. Cancer to bone: a fatal attraction. Nat. Rev. Cancer 11, 411\u2013425 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm3961_CR5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ctrv.2010.04.003","volume":"36","author":"RE Coleman","year":"2010","unstructured":"Coleman, R.E. et al. Metastasis and bone loss: advancing treatment and prevention. Cancer Treat. Rev. 36, 615\u2013620 (2010).","journal-title":"Cancer Treat. Rev."},{"key":"BFnm3961_CR6","doi-asserted-by":"publisher","first-page":"13909","DOI":"10.1073\/pnas.0506517102","volume":"102","author":"Y Kang","year":"2005","unstructured":"Kang, Y. et al. Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc. Natl. Acad. Sci. USA 102, 13909\u201313914 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3961_CR7","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/nm.1943","volume":"15","author":"M Korpal","year":"2009","unstructured":"Korpal, M. et al. Imaging transforming growth factor-\u03b2 signaling dynamics and therapeutic response in breast cancer bone metastasis. Nat. Med. 15, 960\u2013966 (2009).","journal-title":"Nat. Med."},{"key":"BFnm3961_CR8","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nm.1979","volume":"15","author":"Y Tang","year":"2009","unstructured":"Tang, Y. et al. TGF-\u03b21\u2013induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat. Med. 15, 757\u2013765 (2009).","journal-title":"Nat. Med."},{"key":"BFnm3961_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev.biochem.76.053105.094237","volume":"76","author":"R Zalk","year":"2007","unstructured":"Zalk, R., Lehnart, S.E. & Marks, A.R. Modulation of the ryanodine receptor and intracellular calcium. Annu. Rev. Biochem. 76, 367\u2013385 (2007).","journal-title":"Annu. Rev. Biochem."},{"key":"BFnm3961_CR10","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cmet.2011.05.014","volume":"14","author":"DC Andersson","year":"2011","unstructured":"Andersson, D.C. et al. Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. Cell Metab. 14, 196\u2013207 (2011).","journal-title":"Cell Metab."},{"key":"BFnm3961_CR11","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1172\/JCI118947","volume":"98","author":"TA Guise","year":"1996","unstructured":"Guise, T.A. et al. Evidence for a causal role of parathyroid hormone\u2013related protein in the pathogenesis of human breast cancer\u2013mediated osteolysis. J. Clin. Invest. 98, 1544\u20131549 (1996).","journal-title":"J. Clin. Invest."},{"key":"BFnm3961_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.critrevonc.2011.01.004","volume":"80","author":"L Vera-Ramirez","year":"2011","unstructured":"Vera-Ramirez, L. et al. Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies. Crit. Rev. Oncol. Hematol. 80, 347\u2013368 (2011).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"BFnm3961_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nm.1916","volume":"15","author":"AM Bellinger","year":"2009","unstructured":"Bellinger, A.M. et al. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat. Med. 15, 325\u2013330 (2009).","journal-title":"Nat. Med."},{"key":"BFnm3961_CR14","doi-asserted-by":"publisher","first-page":"9385","DOI":"10.1073\/pnas.0900108106","volume":"106","author":"X Lu","year":"2009","unstructured":"Lu, X. & Kang, Y. Efficient acquisition of dual metastasis organotropism to bone and lung through stable spontaneous fusion between MDA-MB-231 variants. Proc. Natl. Acad. Sci. USA 106, 9385\u20139390 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3961_CR15","first-page":"40","volume":"77","author":"TA Guise","year":"1993","unstructured":"Guise, T.A., Yoneda, T., Yates, A.J. & Mundy, G.R. The combined effect of tumor-produced parathyroid hormone\u2013related protein and transforming growth factor-\u03b1 enhance hypercalcemia in vivo and bone resorption in vitro. J. Clin. Endocrinol. Metab. 77, 40\u201345 (1993).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnm3961_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1359\/jbmr.1999.14.2.256","volume":"14","author":"H Hjorth-Hansen","year":"1999","unstructured":"Hjorth-Hansen, H. et al. Marked osteoblastopenia and reduced bone formation in a model of multiple myeloma bone disease in severe combined immunodeficiency mice. J. Bone Miner. Res. 14, 256\u2013263 (1999).","journal-title":"J. Bone Miner. Res."},{"key":"BFnm3961_CR17","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1073\/pnas.0711074105","volume":"105","author":"AM Bellinger","year":"2008","unstructured":"Bellinger, A.M. et al. Remodeling of ryanodine receptor complex causes 'leaky' channels: a molecular mechanism for decreased exercise capacity. Proc. Natl. Acad. Sci. USA 105, 2198\u20132202 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3961_CR18","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1016\/j.ddmec.2010.09.009","volume":"7","author":"DC Andersson","year":"2010","unstructured":"Andersson, D.C. & Marks, A.R. Fixing ryanodine receptor Ca leak: a novel therapeutic strategy for contractile failure in heart and skeletal muscle. Drug Discov. Today Dis. Mech. 7, e151\u2013e157 (2010).","journal-title":"Drug Discov. Today Dis. Mech."},{"key":"BFnm3961_CR19","doi-asserted-by":"publisher","first-page":"21352","DOI":"10.1074\/jbc.M111663200","volume":"277","author":"SL Dallas","year":"2002","unstructured":"Dallas, S.L., Rosser, J.L., Mundy, G.R. & Bonewald, L.F. Proteolysis of latent transforming growth factor-\u03b2 (TGF-\u03b2)-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-\u03b2 from bone matrix. J. Biol. Chem. 277, 21352\u201321360 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnm3961_CR20","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","volume":"3","author":"Y Kang","year":"2003","unstructured":"Kang, Y. et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537\u2013549 (2003).","journal-title":"Cancer Cell"},{"key":"BFnm3961_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1172\/JCI3523","volume":"103","author":"JJ Yin","year":"1999","unstructured":"Yin, J.J. et al. TGF-\u03b2 signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J. Clin. Invest. 103, 197\u2013206 (1999).","journal-title":"J. Clin. Invest."},{"key":"BFnm3961_CR22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Y Shi","year":"2003","unstructured":"Shi, Y. & Massagu\u00e9, J. Mechanisms of TGF-\u03b2 signaling from cell membrane to the nucleus. Cell 113, 685\u2013700 (2003).","journal-title":"Cell"},{"key":"BFnm3961_CR23","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.4049\/jimmunol.142.5.1536","volume":"142","author":"JR Dasch","year":"1989","unstructured":"Dasch, J.R., Pace, D.R., Waegell, W., Inenaga, D. & Ellingsworth, L. Monoclonal antibodies recognizing transforming growth factor\u2013\u03b2. Bioactivity neutralization and transforming growth factor \u03b22 affinity purification. J. Immunol. 142, 1536\u20131541 (1989).","journal-title":"J. Immunol."},{"key":"BFnm3961_CR24","doi-asserted-by":"publisher","first-page":"e27090","DOI":"10.1371\/journal.pone.0027090","volume":"6","author":"S Biswas","year":"2011","unstructured":"Biswas, S. et al. Anti\u2013transforming growth factor ss antibody treatment rescues bone loss and prevents breast cancer metastasis to bone. PLoS ONE 6, e27090 (2011).","journal-title":"PLoS ONE"},{"key":"BFnm3961_CR25","doi-asserted-by":"publisher","first-page":"16098","DOI":"10.1073\/pnas.1109546108","volume":"108","author":"QA Sun","year":"2011","unstructured":"Sun, Q.A. et al. Oxygen-coupled redox regulation of the skeletal muscle ryanodine receptor-Ca2+ release channel by NADPH oxidase 4. Proc. Natl. Acad. Sci. USA 108, 16098\u201316103 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3961_CR26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jhep.2008.07.021","volume":"49","author":"I Carmona-Cuenca","year":"2008","unstructured":"Carmona-Cuenca, I. et al. Upregulation of the NADPH oxidase NOX4 by TGF-\u03b2 in hepatocytes is required for its pro-apoptotic activity. J. Hepatol. 49, 965\u2013976 (2008).","journal-title":"J. Hepatol."},{"key":"BFnm3961_CR27","doi-asserted-by":"publisher","first-page":"932","DOI":"10.18632\/aging.100520","volume":"4","author":"S Hubackova","year":"2012","unstructured":"Hubackova, S., Krejcikova, K., Bartek, J. & Hodny, Z. IL1- and TGF-\u03b2\u2013Nox4 signaling, oxidative stress and DNA damage response are shared features of replicative, oncogene-induced and drug-induced paracrine 'bystander senescence'. Aging (Albany NY) 4, 932\u2013951 (2012).","journal-title":"Aging (Albany NY)"},{"key":"BFnm3961_CR28","doi-asserted-by":"publisher","first-page":"L295","DOI":"10.1152\/ajplung.00134.2010","volume":"300","author":"C Michaeloudes","year":"2011","unstructured":"Michaeloudes, C., Sukkar, M.B., Khorasani, N.M., Bhavsar, P.K. & Chung, K.F. TGF-\u03b2 regulates Nox4, MnSOD and catalase expression and IL-6 release in airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 300, L295\u2013L304 (2011).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"BFnm3961_CR29","doi-asserted-by":"publisher","first-page":"e1010","DOI":"10.1038\/cddis.2013.551","volume":"5","author":"F Yan","year":"2014","unstructured":"Yan, F. et al. Nox4 and redox signaling mediate TGF-\u03b2\u2013induced endothelial cell apoptosis and phenotypic switch. Cell Death Dis. 5, e1010 (2014).","journal-title":"Cell Death Dis."},{"key":"BFnm3961_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.freeradbiomed.2012.05.007","volume":"53","author":"JX Jiang","year":"2012","unstructured":"Jiang, J.X. et al. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4\/NOX1 inhibitor in vivo. Free Radic. Biol. Med. 53, 289\u2013296 (2012).","journal-title":"Free Radic. Biol. Med."},{"key":"BFnm3961_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/81563","volume":"26","author":"K Janssens","year":"2000","unstructured":"Janssens, K. et al. Mutations in the gene encoding the latency-associated peptide of TGF-\u03b21 cause Camurati-Engelmann disease. Nat. Genet. 26, 273\u2013275 (2000).","journal-title":"Nat. Genet."},{"key":"BFnm3961_CR32","doi-asserted-by":"publisher","first-page":"7718","DOI":"10.1074\/jbc.M208857200","volume":"278","author":"K Janssens","year":"2003","unstructured":"Janssens, K., ten Dijke, P., Ralston, S.H., Bergmann, C. & Van Hul, W. Transforming growth factor-\u03b21 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein. J. Biol. Chem. 278, 7718\u20137724 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnm3961_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/mus.22232","volume":"45","author":"CL Mendias","year":"2012","unstructured":"Mendias, C.L. et al. Transforming growth factor-\u03b2 induces skeletal muscle atrophy and fibrosis through the induction of atrogin-1 and scleraxis. Muscle Nerve 45, 55\u201359 (2012).","journal-title":"Muscle Nerve"},{"key":"BFnm3961_CR34","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","volume":"142","author":"X Zhou","year":"2010","unstructured":"Zhou, X. et al. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 142, 531\u2013543 (2010).","journal-title":"Cell"},{"key":"BFnm3961_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/387083a0","volume":"387","author":"AC McPherron","year":"1997","unstructured":"McPherron, A.C., Lawler, A.M. & Lee, S.J. Regulation of skeletal muscle mass in mice by a new TGF-\u03b2 superfamily member. Nature 387, 83\u201390 (1997).","journal-title":"Nature"},{"key":"BFnm3961_CR36","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nature01154","volume":"420","author":"S Bogdanovich","year":"2002","unstructured":"Bogdanovich, S. et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature 420, 418\u2013421 (2002).","journal-title":"Nature"},{"key":"BFnm3961_CR37","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1126\/science.1094301","volume":"304","author":"XH Wehrens","year":"2004","unstructured":"Wehrens, X.H. et al. Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 304, 292\u2013296 (2004).","journal-title":"Science"},{"key":"BFnm3961_CR38","doi-asserted-by":"publisher","first-page":"e6896","DOI":"10.1371\/journal.pone.0006896","volume":"4","author":"LK Dunn","year":"2009","unstructured":"Dunn, L.K. et al. Hypoxia and TGF-\u03b2 drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment. PLoS ONE 4, e6896 (2009).","journal-title":"PLoS ONE"},{"key":"BFnm3961_CR39","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1093\/jnci\/51.5.1409","volume":"51","author":"HD Soule","year":"1973","unstructured":"Soule, H.D., Vazguez, J., Long, A., Albert, S. & Brennan, M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51, 1409\u20131416 (1973).","journal-title":"J. Natl. Cancer Inst."},{"key":"BFnm3961_CR40","doi-asserted-by":"publisher","first-page":"10954","DOI":"10.1073\/pnas.1830978100","volume":"100","author":"JJ Yin","year":"2003","unstructured":"Yin, J.J. et al. A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases. Proc. Natl. Acad. Sci. USA 100, 10954\u201310959 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3961_CR41","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1089\/hum.2012.040","volume":"23","author":"Z Hu","year":"2012","unstructured":"Hu, Z. et al. Systemic delivery of oncolytic adenoviruses targeting transforming growth factor-\u03b2 inhibits established bone metastasis in a prostate cancer mouse model. Hum. Gene Ther. 23, 871\u2013882 (2012).","journal-title":"Hum. Gene Ther."},{"key":"BFnm3961_CR42","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s10585-014-9682-1","volume":"31","author":"RW Johnson","year":"2014","unstructured":"Johnson, R.W. et al. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer. Clin. Exp. Metastasis 31, 945\u2013959 (2014).","journal-title":"Clin. Exp. Metastasis"},{"key":"BFnm3961_CR43","first-page":"93","volume":"75","author":"N Jackson","year":"1989","unstructured":"Jackson, N. et al. Two new IgA1-\u03ba plasma cell leukaemia cell lines (JJN-1 & JJN-2) which proliferate in response to B cell stimulatory factor 2. Clin. Exp. Immunol. 75, 93\u201399 (1989).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnm3961_CR44","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/bonekey.2015.101","volume":"4","author":"A Bonetto","year":"2015","unstructured":"Bonetto, A., Andersson, D.C. & Waning, D.L. Assessment of muscle mass and strength in mice. Bonekey Rep. 4, 732 (2015).","journal-title":"Bonekey Rep."},{"key":"BFnm3961_CR45","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1002\/art.24907","volume":"60","author":"T Yamada","year":"2009","unstructured":"Yamada, T. et al. Impaired myofibrillar function in the soleus muscle of mice with collagen-induced arthritis. Arthritis Rheum. 60, 3280\u20133289 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnm3961_CR46","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/hmg\/ddn355","volume":"18","author":"J Aydin","year":"2009","unstructured":"Aydin, J. et al. Increased mitochondrial Ca2+ and decreased sarcoplasmic reticulum Ca2+ in mitochondrial myopathy. Hum. Mol. Genet. 18, 278\u2013288 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm3961_CR47","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1002\/prca.200780140","volume":"2","author":"X Lai","year":"2008","unstructured":"Lai, X. et al. Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients. Proteomics Clin. Appl. 2, 1140\u20131152 (2008).","journal-title":"Proteomics Clin. Appl."},{"key":"BFnm3961_CR48","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1021\/ac025747h","volume":"74","author":"A Keller","year":"2002","unstructured":"Keller, A., Nesvizhskii, A.I., Kolker, E. & Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS\/MS and database search. Anal. Chem. 74, 5383\u20135392 (2002).","journal-title":"Anal. Chem."},{"key":"BFnm3961_CR49","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1021\/ac0341261","volume":"75","author":"AI Nesvizhskii","year":"2003","unstructured":"Nesvizhskii, A.I., Keller, A., Kolker, E. & Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75, 4646\u20134658 (2003).","journal-title":"Anal. Chem."},{"key":"BFnm3961_CR50","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1021\/pr2005633","volume":"10","author":"X Lai","year":"2011","unstructured":"Lai, X., Wang, L., Tang, H. & Witzmann, F.A. A novel alignment method and multiple filters for exclusion of unqualified peptides to enhance label-free quantification using peptide intensity in LC-MS\/MS. J. Proteome Res. 10, 4799\u20134812 (2011).","journal-title":"J. Proteome Res."},{"key":"BFnm3961_CR51","doi-asserted-by":"publisher","first-page":"e5275","DOI":"10.1371\/journal.pone.0005275","volume":"4","author":"KS Mohammad","year":"2009","unstructured":"Mohammad, K.S. et al. Pharmacologic inhibition of the TGF-\u03b2 type I receptor kinase has anabolic and anti-catabolic effects on bone. PLoS ONE 4, e5275 (2009).","journal-title":"PLoS ONE"},{"key":"BFnm3961_CR52","doi-asserted-by":"publisher","first-page":"21726","DOI":"10.1074\/jbc.271.36.21726","volume":"271","author":"Y Kimura","year":"1996","unstructured":"Kimura, Y., Kurzydlowski, K., Tada, M. & MacLennan, D.H. Phospholamban regulates the Ca2+-ATPase through intramembrane interactions. J. Biol. Chem. 271, 21726\u201321731 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFnm3961_CR53","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0006-3495(99)77229-2","volume":"76","author":"H Cheng","year":"1999","unstructured":"Cheng, H. et al. Amplitude distribution of calcium sparks in confocal images: theory and studies with an automatic detection method. Biophys. J. 76, 606\u2013617 (1999).","journal-title":"Biophys. J."},{"key":"BFnm3961_CR54","first-page":"1","volume":"18","author":"JCF de Winter","year":"2013","unstructured":"de Winter, J.C.F. Using the Student's t-test with extremely small sample sizes. Pract. Assess., Res. Eval. 18, 1\u201312 (2013).","journal-title":"Pract. Assess., Res. Eval."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.3961.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3961","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3961.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T01:23:44Z","timestamp":1692062624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.3961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,12]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["BFnm3961"],"URL":"https:\/\/doi.org\/10.1038\/nm.3961","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725846029.793535152","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,12]]},"assertion":[{"value":"3 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.R.M. is a member of the board and consults for ARMGO Pharma Inc., a startup company developing RyR-targeted therapeutics; T.A.G. was a consultant and advisory board member for Novartis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}